Research Article
Presentation of Infectious Keratitis to ED during COVID-19 Lockdown
Table 2
Clinical details.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
Treatment, all patients receiving described treatment, including combination therapy. Cef/Vanc, ceftazidime/vancomycin; PHMB, polyhexamethylene biguanide; others, antifungal and antiviral therapy. |